{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:42:45Z","timestamp":1763660565981,"version":"3.45.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12308-025-00670-6","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:30:43Z","timestamp":1763659843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel splicing variant of CNTRL::FGFR1 in myeloid\/lymphoid neoplasm with eosinophilia and rearrangement of FGFR1"],"prefix":"10.1007","volume":"18","author":[{"given":"Xianqi","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoju","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaobin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"4","key":"670_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.humpath.2009.11.003","volume":"41","author":"CC Jackson","year":"2010","unstructured":"Jackson CC, Medeiros LJ, Miranda RN (2010) 8p11 myeloproliferative syndrome: a review. Hum Pathol 41(4):461\u2013476","journal-title":"Hum Pathol"},{"issue":"1","key":"670_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1182\/blood-2002-02-0577","volume":"101","author":"G Guasch","year":"2003","unstructured":"Guasch G, Popovici C, Mugneret F, Chaffanet M, Pontarotti P, Birnbaum D, Pebusque MJ (2003) Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood 101(1):286\u2013288","journal-title":"Blood"},{"issue":"7","key":"670_CR3","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36(7):1703\u20131719","journal-title":"Leukemia"},{"issue":"1","key":"670_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00428-022-03402-8","volume":"482","author":"A Tzankov","year":"2023","unstructured":"Tzankov A, Reichard KK, Hasserjian RP, Arber DA, Orazi A, Wang SA (2023) Updates on eosinophilic disorders. Virchows Arch 482(1):85\u201397","journal-title":"Virchows Arch"},{"issue":"6","key":"670_CR5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/his.15021","volume":"83","author":"L Saft","year":"2023","unstructured":"Saft L, Kvasnicka HM, Boudova L, Gianelli U, Lazzi S, Rozman M (2023) Myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: a workshop report with focus on novel entities and a literature review including paediatric cases. Histopathology 83(6):829\u2013849","journal-title":"Histopathology"},{"issue":"1","key":"670_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/16078454.2020.1854493","volume":"26","author":"M Chen","year":"2021","unstructured":"Chen M, Wang K, Cai X, Zhang X, Chao H, Chen S, Shen H, Wang Q, Zhang R (2021) Myeloid\/lymphoid neoplasm with CEP110-FGFR1 fusion: an analysis of 16 cases show common features and poor prognosis. Hematology 26(1):153\u2013159","journal-title":"Hematology"},{"issue":"3","key":"670_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000481392","volume":"139","author":"H Lv","year":"2018","unstructured":"Lv H, Hu S, Lu J, Zhai Q, Zhai Z, Du Z, Sun Y, Li J, He H, Wang Y (2018) Precursor T-lymphoblastic lymphoma associated with t(8;9)(p11.2;q33): a case report and review of the literature. Acta Haematol 139(3):176\u2013182","journal-title":"Acta Haematol"},{"issue":"8","key":"670_CR8","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/annonc\/mdy173","volume":"29","author":"S Verstovsek","year":"2018","unstructured":"Verstovsek S, Subbiah V, Masarova L, Yin CC, Tang G, Manshouri T, Asatiani E, Daver NG (2018) Treatment of the myeloid\/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor. Ann Oncol 29(8):1880\u20131882","journal-title":"Ann Oncol"},{"issue":"11","key":"670_CR9","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1016\/j.leukres.2010.06.027","volume":"34","author":"L Zhou","year":"2010","unstructured":"Zhou L, Fu W, Yuan Z, Hou J (2010) Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome. Leuk Res 34(11):e306-307","journal-title":"Leuk Res"},{"issue":"8","key":"670_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/10245332.2018.1446279","volume":"23","author":"K Umino","year":"2018","unstructured":"Umino K, Fujiwara SI, Ikeda T, Toda Y, Ito S, Mashima K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y et al (2018) Clinical outcomes of myeloid\/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. Hematology 23(8):470\u2013477","journal-title":"Hematology"},{"issue":"3","key":"670_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41409-021-01553-x","volume":"57","author":"JC Hernandez-Boluda","year":"2022","unstructured":"Hernandez-Boluda JC, Pereira A, Zinger N, Gras L, Martino R, Nikolousis E, Finke J, Chinea A, Rambaldi A, Robin M et al (2022) Allogeneic hematopoietic cell transplantation in patients with myeloid\/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplant 57(3):416\u2013422","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"670_CR12","doi-asserted-by":"publisher","first-page":"EVIDoa2500017","DOI":"10.1056\/EVIDoa2500017","volume":"4","author":"S Verstovsek","year":"2025","unstructured":"Verstovsek S, Kiladjian JJ, Vannucchi AM, Patel JL, Rambaldi A, Shomali WE, Oh ST, Usuki K, Harrison CN, Ritchie EK et al (2025) Pemigatinib for myeloid\/lymphoid neoplasms with FGFR1 rearrangement. NEJM Evidence 4(9):EVIDoa2500017","journal-title":"NEJM Evidence"},{"issue":"8","key":"670_CR13","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.3324\/haematol.2017.187302","volume":"103","author":"C Baer","year":"2018","unstructured":"Baer C, Muehlbacher V, Kern W, Haferlach C, Haferlach T (2018) Molecular genetic characterization of myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2. Haematologica 103(8):e348\u2013e350","journal-title":"Haematologica"},{"issue":"7","key":"670_CR14","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1080\/10428194.2017.1397663","volume":"59","author":"P Strati","year":"2018","unstructured":"Strati P, Tang G, Duose DY, Mallampati S, Luthra R, Patel KP, Hussaini M, Mirza AS, Komrokji RS, Oh S et al (2018) Myeloid\/lymphoid neoplasms with FGFR1 rearrangement. Leuk Lymphoma 59(7):1672\u20131676","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00670-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00670-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00670-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:30:43Z","timestamp":1763659843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00670-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00670-6","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}